Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Active not recruiting 2Terminated 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 6

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Breast 13Gastrointestinal 7Tumor-Agnostic 6Thoracic 6Genitourinary 6Gynecologic 5Other hematologic neoplasm 3Head & Neck 3CNS 3Lymphoid 2Dermatologic 2Plasma cell 1Other 1

Conditions

Neoplasms 6

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Focus Groups × Tumor-Agnostic × Clear all
NCT06549153 2026-03-09

ACT-Together (Acting on Cancer Testing-Together)

M.D. Anderson Cancer Center

Phase NA Active not recruiting
30 enrolled
Tumor-Agnostic

Neoplasms

NCT00832325 2026-03-03

Adolescent and Young Adult Cancer Survivors: Identity Development

Memorial Sloan Kettering Cancer Center

Active not recruiting
300 enrolled
Tumor-Agnostic

Neoplasms

NCT05694650 2026-03-03

Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.

M.D. Anderson Cancer Center

Recruiting
20 enrolled
Tumor-Agnostic

Neoplasms

NCT07105046 2026-03-02

Facilitators and Barriers to Cancer Treatment Among Texas Residents

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
120 enrolled
Tumor-Agnostic

Neoplasms

NCT05244915 2025-01-06

A Supportive Care Intervention for Older Caregivers of Older Adults with Advanced Cancer

University of Rochester

Phase NA Terminated
73 enrolled
Tumor-Agnostic

Neoplasms

NCT02651831 2024-01-17

FACT-ICM

University Health Network, Toronto

Completed
85 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡